OTCBlaze Newsletter March 19, 2010 OTCBlaze Members, Before getting into a great positive, we would like to start out by saying sorry for the way
WBRE performed today. Everything really looked good going into this morning; however, pure greed took over and massive selling kicked in. Once she hit .38, we quickly noticed a dump was forthcoming (based on L2), which is why we quickly warned you, so you could limit any loss. We really hope you got out quickly!!! We do our best to avoid the "bad eggs" in the penny world, but on occasion we run into them. After today`s mess, our team decided to implement additional risk/reward assessments for each of our future picks. Although this is not bulletproof, we think it will help. As we all know, the penny market has great risk, but also great reward!! 99% of our picks provide you with the opportunity to make profitable trades and we will continue making great picks.
So, let`s move on to some positive news! 3 weeks ago we alerted
SOMX at 3.1305 and it has done well. Today, the FDA approved the New Drug Application for Silenor (doxepin) for the treatment of insomnia....then KABOOM!
SOMX ran up to 10.01 for a 220% gain from our alert!!! Congrats to those members who were in
SOMX.
We love the pharma plays and will continue to research them to find hidden gems or those with great forward-looking events.
Please read our disclaimer in full and best of luck to you with your investment decisions.
Read Disclaimer
See OTC Blaze's website for full disclaimer. OTC Blaze may have received compensation for stock picks.